Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP332044.RAPwcjI-2xABtkzTYMNrX-ydvK1J6OzdWjrPADvYYeFUw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP332044.RAPwcjI-2xABtkzTYMNrX-ydvK1J6OzdWjrPADvYYeFUw130_assertion type Assertion NP332044.RAPwcjI-2xABtkzTYMNrX-ydvK1J6OzdWjrPADvYYeFUw130_head.
- NP332044.RAPwcjI-2xABtkzTYMNrX-ydvK1J6OzdWjrPADvYYeFUw130_assertion description "[Fusion gene products such as PML-RARalpha and BCR-ABL generated by leukemia-specific chromosomal translocations have been identified as target molecules for the treatment of leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP332044.RAPwcjI-2xABtkzTYMNrX-ydvK1J6OzdWjrPADvYYeFUw130_provenance.
- NP332044.RAPwcjI-2xABtkzTYMNrX-ydvK1J6OzdWjrPADvYYeFUw130_assertion evidence source_evidence_literature NP332044.RAPwcjI-2xABtkzTYMNrX-ydvK1J6OzdWjrPADvYYeFUw130_provenance.
- NP332044.RAPwcjI-2xABtkzTYMNrX-ydvK1J6OzdWjrPADvYYeFUw130_assertion SIO_000772 11587362 NP332044.RAPwcjI-2xABtkzTYMNrX-ydvK1J6OzdWjrPADvYYeFUw130_provenance.
- NP332044.RAPwcjI-2xABtkzTYMNrX-ydvK1J6OzdWjrPADvYYeFUw130_assertion wasDerivedFrom befree-2016 NP332044.RAPwcjI-2xABtkzTYMNrX-ydvK1J6OzdWjrPADvYYeFUw130_provenance.
- NP332044.RAPwcjI-2xABtkzTYMNrX-ydvK1J6OzdWjrPADvYYeFUw130_assertion wasGeneratedBy ECO_0000203 NP332044.RAPwcjI-2xABtkzTYMNrX-ydvK1J6OzdWjrPADvYYeFUw130_provenance.